loganic acid has been researched along with Colitis, Ulcerative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S; Naidu, VGM; Panda, SR; Prakash, AN; Prasad, N; Puppala, ER; Ravichandiran, V; Singh, M | 1 |
1 other study(ies) available for loganic acid and Colitis, Ulcerative
| Article | Year |
|---|---|
Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Caco-2 Cells; Colitis, Ulcerative; Dextran Sulfate; Humans; Inflammation; Mice; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Sirtuin 1; Toll-Like Receptor 4 | 2023 |